�鶹��ýӰ��

Oncology/Hematology >

Hematology

News, opinions and meeting coverage in oncology/hematology.

ASCO over a photo of McCormick Place in Chicago, IL

Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial

Better efficacy with brentuximab vedotin versus standard chemo, substantially less toxicity

Onco Break over a computer rendering of a cancer cell.

Fewer Suicides in Cancer Patients; Circadian Rhythm Boost; HIV Vaccine for Cancer?

News, features, and commentary about cancer-related issues

ASCO over a photo of McCormick Place, in Chicago, IL

STAMP Inhibitor Tops Imatinib, Second-Gen TKIs for Newly Diagnosed CML

The benefit-risk profile could change the treatment paradigm in CML, expert says

A photo of a male artist tattooing his male client in a parlor in Stockholm, Sweden.

Tattoos May Be a Risk Factor for Lymphoma

Swedish study suggests a 21% higher risk for lymphoma in those with tattoos

The YouTube thumbnail for this video with a cartoon nurse and the words: MOST BURNT OUT SPECIALTY

Five Doctor �鶹��ýӰ�� With the Most Burnout in 2024

Emergency medicine and ob/gyn top the list

A computer rendering of antibodies in the blood.

Doubt Cast on MGUS-Autoimmune Disease Link

Population-based study fails to confirm earlier findings

A photo of infected blood victim Brendan West.

What to Know About the U.K.'s Tainted Blood Scandal

Tens of thousands contracted HIV or hepatitis from transfusions during the 1970s and 1980s

Mortality in U.S. Youth; Gene Therapy for Sickle Cell Disease

Also in TTHealthWatch: updated breast cancer screening guidelines

Onco Break over a computer rendering of a cancer cell.

Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise

News, features, and commentary about cancer-related issues

A computer rendering of acute myeloid leukemia cells in the blood.

Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Show

Study finds survival is comparable to that seen in younger patients in VIALE-A trial

A photo of a box of Adzynma

Impact of Recombinant Replacement Therapy Detailed in Genetic Clotting Disorder

Trial that led to FDA approval shows a big difference in replacement levels versus usual care

A photo of a lab technician using a pipette to transfer a sample to a multi well plate in a laboratory.

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management

Genetics already informs prognosis, may help guide therapy development beyond JAK2 inhibition

A computer rendering of Myelofibrosis cells in the blood

Myelofibrosis: A Rare Malignancy Attracting More and More Attention

Increased interest follows mutation discoveries, development of targeted therapies

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

New E. Coli Outbreak; How ECMO Redefines Death; A Step Closer to Universal Blood

Health news and commentary gathered by MedPage Today staff

FDA APPROVED mavorixafor (Xolremdi) over a photo of warts on a woman’s hand.

FDA Approves First Drug for WHIM Syndrome

CXCR4 antagonist mavorixafor effectively boosts neutrophils and lymphocytes to reduce infections

Onco Break over a computer rendering of a cancer cell.

Clue to Aspirin, Colon Cancer Link; New Lutathera Approval; AI & Electronic Records

News, features, and commentary about cancer-related issues

Illustration of red blood cells.

FDA OKs Second Gene Therapy for Hemophilia B

One dose of fidanacogene elaparvovec proved noninferior to standard prophylactic factor IX

An image of isatuximab tablets.

Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCT

ORR reaches 90% with isatuximab plus KRd in newly diagnosed disease

Illustration of blood cells with circulating tumor cells.

High Deep-Remission Rate With Triple Regimen for Relapsed/Refractory CLL

Undetectable disease rate over 90%, ctDNA also promising for earlier detection of recurrence

Illustration of an engineered T-cell attacking a leukemia cell.

CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers

"All-in-one" approach appears safe, effective, in patients with relapsed/refractory disease

A photo of a pregnant woman napping while receiving chemotherapy.

Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs

However, use should be avoided "if possible" due to risk of rare immune-related adverse events

FDA APPROVED ciltacabtagene autoleucel (Carvykti), idecabtagene vicleucel (Abecma) over 3D multiple myeloma cells.

FDA Approves Earlier Use of CAR-T Products for Myeloma

Carvykti and Abecma move to second- and third-line, respectively

ACC over a photo of Georgia World Congress Center in Atlanta, GA

High Response Rate in R/R Multiple Myeloma With Bispecific Antibody

ORR of 71% that deepened over time and favorable safety profile with linvoseltamab

FDA APPROVED danicopan (Voydeya) over a computer rendering of red blood cells.

Factor D Inhibitor Wins Approval for PNH With Extravascular Hemolysis

Danicopan significantly improved hemoglobin at 12 weeks when added to a C5 inhibitor

FDA APPROVED ceftobiprole medocaril sodium (Zevtera) over a computer rendering of Staphylococcus aureus bacteria

FDA OKs Injectable Antibiotic for Three Different Uses

Ceftobiprole was at least comparable to currently used medications in studies

Onco Break over a computer rendering of a cancer cell.

Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations

News, features, and commentary about cancer-related issues

A computer rendering of white blood cells with T-cell lymphoma.

PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma

The combination induced responses in all 34 patients with advanced extranodal NK/T-cell lymphoma

A photo of a woman breastfeeding her baby at home.

Breastfeeding Tied to Reduced Childhood Leukemia Risk

Lower pediatric ALL risk in Danish study when mothers exclusively breastfed for 3 months or more

FDA EUA pemivibart (Pemgarda) over a computer rendering of antibodies attacking COVID viruses.

New Monoclonal Authorized to Prevent COVID in Immunocompromised People

No such option has been available since FDA revoked the authorization of Evusheld last year

FDA APPROVED ponatinib (Iclusig) over a computer rendering of the destruction of lymphoblast cells

FDA Approves New Frontline Regimen for Aggressive ALL

Ponatinib lands indication in combination with chemo for Philadelphia chromosome-positive cases

Onco Break over a computer rendering of a cancer cell.

Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer

News, features, and commentary about cancer-related issues

A photo of a woman reading a book while receiving chemotherapy

Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin

Dose-dependent increase regardless of age at treatment or chest radiotherapy

FDA ODAC ciltacabtagene autoleucel (cilta-cel, Carvykti) and idecabtagene vicleucel (ide-cel, Abecma) over multiple myeloma.

FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma

Cilta-cel, ide-cel win support despite concerns about early mortality risk

FDA APPROVED lisocabtagene maraleucel (Breyanzi) over a computer rendering of CLL cells in the blood stream.

FDA Approves First CAR-T for Chronic Lymphocytic Leukemia

Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL

FDA ODAC imetelstat (Rytelo) over a close up photo of a person receiving a blood transfusion.

FDA Panel Endorses Imetelstat for MDS-Related Anemia

By 12-2 vote, members find improvement in transfusion independence outweighs risk

FDA ODAC ciltacabtagene autoleucel (cilta-cel, Carvykti) and idecabtagene vicleucel (ide-cel, Abecma) over multiple myeloma.

Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myeloma

FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting

Onco Break over a computer rendering of a cancer cell.

Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'

News, features, and commentary about cancer-related issues

FDA ODAC imetelstat (Rytelo) over a close up photo of a person receiving a blood transfusion.

FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia

Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment

A computer rendering of sickle cells in the bloodstream

Sickle Cell Pain Hospitalizations Rose After CDC's Opioid Recs

Agency's 2016 guidance may have contributed to reduced access to opioids, and more pain

Onco Break over a computer rendering of a cancer cell.

A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu

News, features, and commentary about cancer-related issues

3

…